David Lemus serves as the Chief Financial Officer and Chief Operating Officer at miRecule, a pioneering biotechnology company advancing RNA-based therapeutics to address critical unmet medical needs. With over 25 years of experience in financial and operational leadership within the life sciences sector, David is instrumental in steering miRecule’s strategic growth and operational excellence. Prior to joining miRecule, David held senior leadership roles at several prominent biopharmaceutical and healthcare companies. He has a proven track record of securing financing, driving business development initiatives, and optimizing operations to scale innovation and deliver transformative therapies. His expertise spans financial strategy, mergers and acquisitions, fundraising, and global market expansion. At miRecule, David oversees financial planning, investor relations, and day-to-day operations, ensuring alignment between the company’s scientific advancements and business objectives. His leadership has been pivotal in miRecule’s progression from early-stage research to clinical development. David is recognized for his ability to integrate financial acumen with a deep understanding of the biotech landscape, making him a trusted partner to both internal teams and external stakeholders. He holds degrees in finance and business management and actively participates in industry forums, sharing insights to advance the life sciences field.